Modeling asthma: Pitfalls, promises, and the road ahead.
Modeling asthma: Pitfalls, promises, and the road ahead.
复制标题
DOI:
10.1002/jlb.3mr1117-436r
复制
发表时间:
2018-07
影响因子:
5.5
通讯作者:
Druey KM
中科院分区:
文献类型:
--
作者:
Rosenberg HF;Druey KM
Asthma is a chronic, heterogeneous and recurring inflammatory disease of the lower airways, with exacerbations that feature airway inflammation and bronchial hyperresponsiveness. Asthma has been modeled extensively via disease induction in both wild-type and genetically manipulated laboratory mice (Mus musculus). Antigen sensitization and challenge strategies have reproduced numerous important features of airway inflammation characteristic of human asthma, notably the critical roles of Th2 cytokines. Recent models of disease induction have advanced to include physiologic aeroallergens with prolonged respiratory challenge without systemic sensitization; others incorporate tobacco, respiratory viruses or bacteria as exacerbants. Nonetheless, differences in lung size, structure and physiologic responses limit the degree to which airway dynamics measured in mice can be compared to human subjects. Other rodent allergic airways models, including those featuring the guinea pig (Cavia porcellus) might be considered for lung function studies. Finally, domestic cats (Feline catus) and horses (Equus caballus) develop spontaneous obstructive airway disorders with clinical and pathologic features that parallel human asthma. Information on pathogenesis and treatment of these disorders is an important resource. In this mini-review we consider the principles of in vivo modeling together with specific features of animal models for the study of human asthma.